• Genes and health
• Conditions we cover
• Prostate Cancer
• Complete scan
• Cancer scan
• Cardio scan
• Advanced features

deCODEme measures the most important genetic risk variants (SNPs) in prostate cancer that are supported by solid scientific evidence.

The deCODEme Complete Scan analyzes your DNA, identifies 25 common genetic variants associated with increased risk for prostate cancer and provides you with a perzonalized interpretation of your risk. (see what your test results could look like)

At deCODEme, your genetic test for prostate cancer is based on the best science available

Testing your genetic risk for prostate cancer is a personal and private decision

Making the choice to take a genetic risk test for the common genetic variants associated with prostate cancer is a personal and private decision. At deCODEme, we respect your decision and value your trust, and want you to know, that our scientists select only the best, most reliable, science on which to base your results. Needless to say, the security and privacy of your results is one of our biggest priorities.

The deCODEme genetic test for prostate cancer risk is based on solid science

Quality is of utmost importance when you select a provider for genetic testing and we are confident that deCODEme is exceptional when compared to rival products. Our customers benefit directly from the expertise of scientists at deCODE Genetics, a company with an unparalleled track record in gene discovery for common diseases.

We strive to make our genetic scans as comprehensive and reliable as possible. Thus, for any given disease, we measure all the most important genetic risk variants (SNPs) that are supported by solid scientific evidence

Here´s how it works!

deCODEme calculates your genetic risk of prostate cancer

The deCODEme prostate cancer test focuses primarily on identifying the common genetic risk variants associated with prostate cancer. The deCODEme Complete Scan identifies 25 common genetic variants and provides interpretation of their associated risk for developing prostate cancer in men of European descent. For men of African American descent the deCODEme calculates genetic risk associated with the two variants validated in this population. At the present time no risk estimation data are available for people of other ethnicities for the variants mentioned, but will be added as soon as it becomes available and we are assured of its quality.

Test your knowledge of prostate cancer

Prostate cancer has few controllable risk factors. But it’s still important to know your risk and what you can do to lower it. You can test your risk of prostate cancer by visiting the Washington University School of Medicine´s interactive Web site. Take their test and learn more about prostate cancer risks.

more information

You can learn more about prostate cancer by talking to your doctor or other health care provider and visiting these web sites:

• All about prostate cancer from the American Cancer Society
• All about prostate cancer from the Prostate Cancer Institute
• Clinical Trials Homepage – find ongoing clinical trials in prostate cancer
• National Cancer Institute’s Prostate Cancer Fact Sheet
• Prostate cancer from MedlinePlus-Trusted Health Information for You
• Zero-The project to end prostate cancer
• For men only – Cancer symptoms you are likely to ignore from Caring.com – Helping you help your parents

This content was last reviewed on February 09, 2010.

The conditions we cover: ABO Blood Types, Abdominal Aortic Aneurysm, Age Related Macular Degeneration, Alcohol Flush Reaction, Alzheimer’s Disease, Asthma, Atrial Fibrillation, Basal Cell Carcinoma, Bitter Taste Perception, Bladder Cancer, Brain Aneurysm, Brain Cancer-Glioma, Breast Cancer, Celiac Disease, Chronic Kidney Disease, Chronic Lymphocytic Leukemia, Colorectal Cancer, Crohn’s Disease, Essential Tremor, Exfoliation Glaucoma, Eye Color, Gallstones, Gout, Heart Attack, Hemochromatosis, Hypertension, Kidney Stones, Lactose Intolerance, Lung Cancer, Male Pattern Baldness, Multiple Sclerosis, Nicotine Dependence, Obesity, Ovarian Cancer, Pancreatic Cancer, Peripheral Arterial Disease, Prostate Cancer, Psoriasis, Restless Legs Syndrome, Rheumatoid Arthritis, Statin Induced Myopathy, Systemic Lupus Erythematosus, Testicular Cancer, Thyroid Cancer, Type 1 Diabetes, Type 2 Diabetes, Ulcerative Colitis, Venous Thromboembolism, Warfarin Metabolism.